EANM guidelines on the use of [ 18 F]FDG PET/CT in diagnosis, staging, prognostication, therapy assessment, and restaging of plasma cell disorders.

MLA

Nanni, Cristina, et al. “EANM Guidelines on the Use of [ 18 F]FDG PET/CT in Diagnosis, Staging, Prognostication, Therapy Assessment, and Restaging of Plasma Cell Disorders.” European Journal of Nuclear Medicine and Molecular Imaging, Aug. 2024. EBSCOhost, https://doi.org/10.1007/s00259-024-06858-9.

APA

Nanni, C., Deroose, C. M., Balogova, S., Lapa, C., Withofs, N., Subesinghe, M., Jamet, B., Zamagni, E., Ippolito, D., Delforge, M., & Kraeber-Bodéré, F. (2024). EANM guidelines on the use of [ 18 F]FDG PET/CT in diagnosis, staging, prognostication, therapy assessment, and restaging of plasma cell disorders. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-024-06858-9

Chicago

Nanni, Cristina, Christophe M Deroose, Sona Balogova, Constantin Lapa, Nadia Withofs, Manil Subesinghe, Bastien Jamet, et al. 2024. “EANM Guidelines on the Use of [ 18 F]FDG PET/CT in Diagnosis, Staging, Prognostication, Therapy Assessment, and Restaging of Plasma Cell Disorders.” European Journal of Nuclear Medicine and Molecular Imaging, August. doi:10.1007/s00259-024-06858-9.